PT - JOURNAL ARTICLE AU - Vaez, Morteza AU - Montalbano, Simone AU - Calle Sánchez, Xabier AU - Georgii Hellberg, Kajsa-Lotta AU - Rasekhi Dehkordi, Saeid AU - Dybdahl Krebs, Morten AU - Meijsen, Joeri AU - Shorter, John AU - Byberg-Grauholm, Jonas AU - Mortensen, Preben B AU - Børglum, Anders D AU - Hougaard, David M AU - Nordentoft, Merete AU - Geschwind, Daniel H AU - Buil, Alfonso AU - Schork, Andrew J AU - , AU - Helenius, Dorte AU - Raznahan, Armin AU - Thompson, Wesley K AU - Werge, Thomas AU - Ingason, Andrés TI - Population-based Risk of Psychiatric Disorders Associated with Recurrent CNVs AID - 10.1101/2023.09.04.23294975 DP - 2023 Jan 01 TA - medRxiv PG - 2023.09.04.23294975 4099 - http://medrxiv.org/content/early/2023/09/05/2023.09.04.23294975.short 4100 - http://medrxiv.org/content/early/2023/09/05/2023.09.04.23294975.full AB - Recurrent copy number variants (rCNVs) are associated with increased risk of neuropsychiatric disorders but their pathogenic population-level impact is unknown. We provide population-based estimates of rCNV-associated risk of neuropsychiatric disorders for 34 rCNVs in the iPSYCH2015 case-cohort sample (n=120,247).Most observed significant increases in rCNV-associated risk for ADHD, autism or schizophrenia were moderate (HR:1.42-5.00), and risk estimates were highly correlated across these disorders, the most notable exception being high autism-associated risk with Prader-Willi/ Angelman Syndrome duplications (HR=20.8). No rCNV was associated with significant increase in depression risk. Also, rCNV-associated risk was positively correlated with locus size and gene constraint. Comparison with published rCNV studies suggests that prevalence of some rCNVs is higher, and risk of psychiatric disorders lower, than previously estimated.In an era where genetics is increasingly being clinically applied, our results highlight the importance of population-based risk estimates for genetics-based predictions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National Institute of Mental Health (NIMH).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Danish Scientific Ethics gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes"All data produced in the present study (other than sensitive person-level data, which by requirement of the data custodian and Danish legislation cannot be shared; i.e data that corresponds to fewer than 5 individuals) is available upon reasonable request to the corresponding author(s)."